Häuser W, Dietz N, Grandt D, Steder-Neukamm U, Janke K-H, Stein U, Stallmach A
Medizinische Klinik I, Klinikum Saarbrücken, Saarbrücken, Germany.
Z Gastroenterol. 2004 Feb;42(2):131-9. doi: 10.1055/s-2004-812835.
The inflammatory bowel disease questionnaire (IBDQ) is the standard instrument for assessment of health-related quality of life (HRQOL) in patients with inflammatory bowel diseases. It has not been validated for patients with ileal pouch anal anastomosis (IPAA) and ulcerative colitis (UC).
To determine acceptance (percentage of completed items), reliability (Cronbach's alpha of the IBDQ-D subscales) and convergent validity (correlations of the IBDQ subscales with the questionnaires used for validation) 61 patients with UC (age 52.7 +/- 13.9 years; 47 % female, 53 % male) and IPAA completed the German (Competence Network IBD) version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D), the Short Form Health Survey (SF-36) the Hospital Anxiety and Depression Scale German Version (HADS-D) and the Giessener Symptom List (GBB 24). Face validity was assessed by a physicians' and patients' panel. All 37 patients underwent endoscopy making it possible to differentiate between patients with and without pouchitis (discriminant validity).
With 97.7 % completed items the acceptance was high. Cronbach's alpha value for the subscales ranged from 0.71 to 0.93. Missing items covering extraintestinal manifestations of IBD were criticized by patients. The correlation coefficients with comparable subscales of other instruments ranged between 0.41 and 0.76. Patients with clinical pouchitis scored significantly lower in all subscales than patients without pouchitis (p < 0.001).
The IBDQ-D has good acceptance, reliability, convergent and discriminant validity, but limited face and construct validity in patients with IPAA and UC.
炎症性肠病问卷(IBDQ)是评估炎症性肠病患者健康相关生活质量(HRQOL)的标准工具。它尚未在回肠储袋肛管吻合术(IPAA)和溃疡性结肠炎(UC)患者中得到验证。
为确定接受度(完成项目的百分比)、信度(IBDQ - D分量表的克朗巴哈系数)和收敛效度(IBDQ分量表与用于验证的问卷之间的相关性),61例UC患者(年龄52.7±13.9岁;47%为女性,53%为男性)和IPAA患者完成了德语版(炎症性肠病能力网络版)的炎症性肠病问卷(IBDQ - D)、简短健康调查(SF - 36)、医院焦虑抑郁量表德语版(HADS - D)和吉森症状清单(GBB 24)。表面效度由医生和患者小组进行评估。所有37例患者均接受了内镜检查,从而能够区分有无袋炎的患者(判别效度)。
完成项目的比例为97.7%,接受度较高。分量表的克朗巴哈系数值在0.71至0.93之间。患者对涵盖IBD肠外表现的缺失项目提出了批评。与其他工具可比分量表的相关系数在0.41至0.76之间。临床有袋炎患者在所有分量表中的得分均显著低于无袋炎患者(p < 0.001)。
IBDQ - D在IPAA和UC患者中具有良好的接受度、信度、收敛效度和判别效度,但表面效度和结构效度有限。